Sofinnova Partners Closes Oversubscribed €82 Million Sofinnova MD Start IV Fund to Create the Next Generation of Medtech Companies

Contributed by: Business Wire

Logo

Tags

Technology

Finance

Other Technology

Professional Services

Other Health

General Health

Health

Science

Other Science

Other Professional Services

Sofinnova MD Start IV fund

More Like This

Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation

Edward Kliphuis, Partner, Sofinnova Digital Medicine Strategy and Simon Turner, Partner, Sofinnova Digital Medicine Strategy (Photo: Sofinnova Partners)

Sofinnova Partners Raises $200M Digital Medicine Fund

Sofinnova Partners Closes €650M ($750M) Capital XI, Greatly Exceeding Initial Target to Back Early-Stage Healthcare Deals

Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support

Sofinnova Partners Launches Biovelocita, the First Pan-European Investment Strategy Dedicated to the Creation and Acceleration of Biotech Startups

Sofinnova Partners Enhances Leadership in Medtech Acceleration with Key Appointments

Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner

Sofinnova Partners Appoints David Evans as Partner